| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 黄芪生脉饮(元) | 98,439,572.93 | 196,235,899.35 | 105,180,305.88 |
| 伸筋丹胶囊(元) | 11,804,196.55 | 23,446,574.07 | 12,177,268.48 |
| 西洋参口服液(元) | 28,134,440.52 | 40,604,200.12 | 25,218,597.91 |
| 其他(元) | 2,504,523.58 | 7,255,260.70 | 3,576,367.81 |
| 营业成本(元) | |||
| 黄芪生脉饮(元) | 62,190,606.85 | 129,253,675.12 | 69,431,783.07 |
| 伸筋丹胶囊(元) | 6,838,752.05 | 14,740,607.81 | 7,825,516.74 |
| 西洋参口服液(元) | 17,312,671.75 | 25,392,539.11 | 15,637,309.95 |
| 其他(元) | 2,935,655.32 | 7,555,596.06 | 3,519,735.68 |
| 毛利(元) | |||
| 黄芪生脉饮(元) | 36,248,966.08 | 66,982,224.23 | 35,748,522.81 |
| 伸筋丹胶囊(元) | 4,965,444.50 | 8,705,966.26 | 4,351,751.74 |
| 西洋参口服液(元) | 10,821,768.77 | 15,211,661.01 | 9,581,287.96 |
| 其他(元) | -431,131.74 | -300,335.36 | 56,632.13 |
| 毛利率(%) | |||
| 黄芪生脉饮(%) | 36.82 | 34.13 | 33.99 |
| 伸筋丹胶囊(%) | 42.07 | 37.13 | 35.74 |
| 西洋参口服液(%) | 38.46 | 37.46 | 37.99 |
| 其他(%) | -17.21 | -4.14 | 1.58 |
| 收入构成(%) | |||
| 黄芪生脉饮(%) | 69.87 | 73.35 | 71.97 |
| 伸筋丹胶囊(%) | 8.38 | 8.76 | 8.33 |
| 西洋参口服液(%) | 19.97 | 15.18 | 17.25 |
| 其他(%) | 1.78 | 2.71 | 2.45 |
| 毛利构成(%) | |||
| 黄芪生脉饮(%) | 70.24 | 73.93 | 71.87 |
| 伸筋丹胶囊(%) | 9.62 | 9.61 | 8.75 |
| 西洋参口服液(%) | 20.97 | 16.79 | 19.26 |
| 其他(%) | -0.84 | -0.33 | 0.11 |